REFERENCES
- Buajordet I, Naess A C, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004; 11: 19–23, [INFOTRIEVE], [CSA]
- Barton E D, Colwell C B, Wolfe T, et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. Emerg Med 2005; 29: 265–71, [CROSSREF], [CSA]
- Kelly A M, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. Med J Aust 2005; 182: 24–7, [INFOTRIEVE], [CSA]
- Culley L L, Henwood D K, Clark J J, Eisenberg M S. Horton C: Increasing the efficiency of emergency medical services by using criteria based dispatch. Ann Emerg Med 1994; 24: 867–72, [INFOTRIEVE], [CSA]
- Weaver M F. Heroin andother opioids, In UpToDate. www.uptodate.com Accessed August 15, 2006
- Sporer K A. Strategies for preventing heroin overdose. BMJ 2003; 326: 442–4, [INFOTRIEVE], [CROSSREF], [CSA]
- Ashworth A J, Kidd A. Take home naloxone for opiate addicts. Apparent advantages may be balanced by hidden harms. BMJ 2001; 323: 935, [INFOTRIEVE], [CROSSREF], [CSA]
- Wenzel V, Idris A H, Dorges V, et al. The respiratory system during resuscitation: a review of the history, risk of infection during assisted ventilation, respiratory mechanics, andventilation strategies for patients with an unprotected airway. Resuscitation 2001; 49: 123–134, [INFOTRIEVE], [CROSSREF], [CSA]